State Board of Administration of Florida Retirement System continued to hold its position in RTI Surgical Inc. (NASDAQ:RTIX) during the second quarter, Holdings Channel reports. The institutional investor owned 72,601 shares of the company’s stock at the end of the second quarter. State Board of Administration of Florida Retirement System owned approximately 0.12% of RTI Surgical worth $261,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of the company. Metropolitan Life Insurance Co. NY boosted its stake in RTI Surgical by 1.9% in the first quarter. Metropolitan Life Insurance Co. NY now owns 42,735 shares of the company’s stock worth $171,000 after buying an additional 783 shares during the last quarter. Springbok Capital Management LLC boosted its stake in RTI Surgical by 28.7% in the first quarter. Springbok Capital Management LLC now owns 60,628 shares of the company’s stock valued at $243,000 after buying an additional 13,528 shares during the last quarter. Landscape Capital Management L.L.C. bought a new stake in RTI Surgical during the first quarter valued at about $269,000. SG Americas Securities LLC bought a new stake in RTI Surgical during the second quarter valued at about $330,000. Finally, Societe Generale bought a new stake in RTI Surgical during the second quarter valued at about $330,000. 78.97% of the stock is currently owned by institutional investors.
Shares of RTI Surgical Inc. (NASDAQ:RTIX) traded down 0.32% during midday trading on Friday, reaching $3.09. 351,066 shares of the company traded hands. The stock has a 50 day moving average price of $3.15 and a 200 day moving average price of $3.59. RTI Surgical Inc. has a 1-year low of $2.81 and a 1-year high of $5.24. The firm has a market capitalization of $178.52 million, a PE ratio of 43.52 and a beta of 1.57.
RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Wednesday, July 27th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by $0.08. RTI Surgical had a net margin of 2.80% and a return on equity of 6.51%. The business had revenue of $67.60 million for the quarter, compared to analysts’ expectations of $66.52 million. During the same quarter last year, the business earned $0.04 EPS. The company’s quarterly revenue was down 5.6% on a year-over-year basis. Analysts expect that RTI Surgical Inc. will post $0.10 earnings per share for the current fiscal year.
Several equities research analysts have recently issued reports on the stock. Zacks Investment Research cut shares of RTI Surgical from a “buy” rating to a “hold” rating in a research report on Wednesday, June 29th. Craig Hallum cut shares of RTI Surgical from a “buy” rating to a “hold” rating and reduced their price objective for the company from $6.00 to $4.00 in a research report on Thursday, July 28th.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Want to see what other hedge funds are holding RTIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTI Surgical Inc. (NASDAQ:RTIX).
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.